CD274 and hematologic disorder: These results allowed an improved understanding of the exhaustion of human CAR T-cell in solid tumors, suggesting that the effectiveness of CAR T-cell therapies may be improved by PD-1/PD-L1 blockade also in the context of hematological malignancies (38).